Home Cart Sign in  
Chemical Structure| 67-45-8 Chemical Structure| 67-45-8

Structure of Furazolidone
CAS No.: 67-45-8

Chemical Structure| 67-45-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Furazolidone is a Nitrofuran-derived anti-bacterial agent and monoamine oxidase inhibitor.

Synonyms: Furoxone; Trifurox; Furazolidon

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Furazolidone

CAS No. :67-45-8
Formula : C8H7N3O5
M.W : 225.16
SMILES Code : O=C1OCCN1/N=C/C2=CC=C([N+]([O-])=O)O2
Synonyms :
Furoxone; Trifurox; Furazolidon
MDL No. :MFCD00010550

Safety of Furazolidone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H303-H361-H402
Precautionary Statements:P201-P202-P273-P281-P308+P313-P405-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
human hepatocyte L02 cells 10-60 µg/mL 24 hours To evaluate the effect of FZD on L02 cell viability, results showed FZD reduced cell viability in a dose-dependent manner. Molecules. 2016 Aug 22;21(8):1061
Helicobacter pylori ≥2 mg/l 72 hours To evaluate the resistance of Furazolidone against Helicobacter pylori, the results showed a resistance rate of 0.28% (6/2109). Front Cell Infect Microbiol. 2022 Sep 8;12:970630
Giardia lamblia WB C6 100 μM Evaluate the inhibitory effect of furazolidone on Giardia lamblia, results showed that furazolidone was reduced by TrxR, increasing toxicity to the parasite. Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):148-153
Pseudomonas bacteria (Pseudomonas sp. OS4, P. plecoglossicida IsA, Pseudomonas sp. MChB) 5 mg/L 24 hours To assess the effect of furazolidone on bacterial metabolic activity, results showed that FZD combined with saponins significantly reduced bacterial metabolic activity, demonstrating a synergistic bactericidal effect. World J Microbiol Biotechnol. 2023 Jun 5;39(8):221
Human colon epithelial cells CCD 841CoN 5 mg/L 48 hours To evaluate the cytotoxicity of furazolidone combined with saponins, results showed an IC50 of 1.28 µg/mL for FZD, and the addition of saponins did not significantly alter its cytotoxicity. World J Microbiol Biotechnol. 2023 Jun 5;39(8):221
Escherichia coli K12 2.5 μg/mL 24 hours Evaluate the synergy between Furazolidone and Sodium Deoxycholate, showing FICI of 0.125, indicating synergistic inhibition BMC Microbiol. 2020 Jan 6;20(1):5
peripheral blood mononuclear cells (PBMC) >20 µM 72 hours To evaluate the cytotoxicity of Furazolidone on PBMC, results showed no cytotoxic activity on the viability and proliferation of PBMC populations up to 20 µM. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01834-17
Neonatal rat cardiomyocytes (NRCMs) 6.25–100 μM 48 hours To evaluate the effects of furazolidone on cardiomyocyte viability and mitochondrial membrane potential, showing dose-dependent decreases in cell viability and MMP PLoS One. 2013 Jun 20;8(6):e66779

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Furazolidone-induced dilated cardiomyopathy model Gavage 0.3 mg/bodyweight (g)/day Once daily for 8 weeks Induced dilated cardiomyopathy model for subsequent stem cell and gene therapy studies J Cell Mol Med. 2015 Aug;19(8):1868-76
Sprague-Dawley rats Furazolidone-induced dilated cardiomyopathy model Oral 700 ppm Daily administration for thirty weeks To establish a rat model of furazolidone-induced dilated cardiomyopathy, showing enlarged LV dimensions, reduced systolic and diastolic functions, myocardial fibrosis, and mitochondrial damage PLoS One. 2013 Jun 20;8(6):e66779

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03320538 Peptic Ulcer Disease Not Applicable Recruiting July 1, 2019 China, Jiangxi ... More >> Jiangxi University of Traditional Chinese Medicine Recruiting Nanchang, Jiangxi, China, 330004 Contact: Xu Zhou, Ph.D.    +8618780085060    zhouxu_ebm@hotmail.com    Contact: Xiaofan Chen, Ph.D.    +86079187118012    841347982@qq.com Less <<
NCT02689583 Gastritis Gas... More >>tric Ulcer Less << Not Applicable Unknown - -
NCT02934048 Therapeutic Duration ... More >> Helicobacter Pylori Antimicrobial Susceptibility Test Eradication Less << Phase 4 Unknown June 2017 -
NCT02741414 Gastritis Not Applicable Unknown December 2018 China, Zhejiang ... More >> Xianju People Hospital Recruiting Taizhou, Zhejiang, China, 317300 Contact: Hong Li Lyh    13586202668 Less <<
NCT03139253 Antimicrobial Susceptibility T... More >>esting Triple Therapy Less << Phase 4 Not yet recruiting June 30, 2017 -
NCT03297242 - Not yet recruiting September 2018 -
NCT02473796 Acute Respiratory Tract Infect... More >>ions Diarrhea Malaria Neonatal Sepsis Birth Asphyxia Less << Not Applicable Completed - India ... More >> MAHAN Trust, Melghat (Dharni) Amaravati, Maharashtra, India, 444 702 Less <<
NCT02988089 Helicobacter Pylori Infection ... More >> Antimicrobial Susceptibility Testing Less << Phase 4 Recruiting September 2017 China, Shandong ... More >> Department of Gastroenterology, Qilu Hospital, Shandong University Recruiting Ji'nan, Shandong, China, 250012 Contact: Yanqing Li, MD, PhD    86-531-82169236    liyanqing@sdu.edu.cn    Contact: Yanqing Li, MD, PhD    86-0531-82169236    liyanqing@sdu.edu.cn Less <<
NCT03571230 Helicobacter Pylori Infection ... More >> Antimicrobial Susceptibility Testing Less << Phase 4 Not yet recruiting January 30, 2020 China, Shandong ... More >> Xiuli Zuo Not yet recruiting Jinan, Shandong, China Contact: Xiuli Zuo, PhD,MD    15588818685 ext 053188369277    zuoxiuli@sina.com    Sub-Investigator: Jing Liu, MD          Sub-Investigator: Chaoran Ji, MD Less <<
NCT03565484 Helicobacter Pylori Infection Phase 4 Not yet recruiting April 30, 2020 China, Shandong ... More >> Qilu hosipital Not yet recruiting Jinan, Shandong, China, 257000 Contact: Xiuli Zuo, MD,PhD    15588818685 ext 053188369277    zuoxiuli@sina.com    Sub-Investigator: Chaoran Ji, MD          Sub-Investigator: Jing Liu, MD Less <<
NCT03726099 Helicobacter Pylori Infection Phase 4 Not yet recruiting March 30, 2020 China, Shandong ... More >> Xiuli Zuo Jinan, Shandong, China Less <<
NCT01668927 Functional Dyspepsia ... More >> Scarred Peptic Ulcer Less << Phase 4 Completed - China, Shanghai ... More >> Renji Hospital Shanghai, Shanghai, China, 200127 Less <<
NCT01730352 Immune Thrombocytopenic Purpur... More >>a Helicobacter Pylori Infection Less << Phase 2 Phase 3 Completed - Brazil ... More >> Irmandade da Santa Casa de Misericordia se Sao Paulo Sao Paulo, Brazil, 01221-020 Centro de Hematologia de Sao Paulo Sao Paulo, Brazil, 01401-000 Federal University of Sao Paulo Sao Paulo, Brazil, 04021-001 Hospital Estadual Infantil Darcy Vargas Sao Paulo, Brazil, 05614-040 Less <<
NCT03342456 Duodenal Ulcer Due to Helicoba... More >>cter Pylori Less << Phase 4 Recruiting March 20, 2019 China, Hunan ... More >> Hunan Provincial People's Hospital Recruiting Changsha, Hunan, China, 410002 Contact: JIANGTAO LIAO    +8613574899399    jt99399@163.com    Changsha Central Hospital Not yet recruiting Changsha, Hunan, China, 410004 Contact: YA ZENG    +8613637403676       The First Hospital of Changsha City Not yet recruiting Changsha, Hunan, China, 410005 Contact: LI LIU    +8613975119635       Xiangya Hospital of Central South University Not yet recruiting Changsha, Hunan, China, 410008 Contact: MEIHUA XU    +8613787270539    meihuaxu2001@yahoo.com.cn    The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: CHUNLIAN WANG    +8613973161116       The Third Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410013 Contact: CANXIA XU    +8613786176248    xucanxia@163.com    The First Affiliated Hospital of University of South China Not yet recruiting Hengyang, Hunan, China, 421001 Contact: AIJUN LIAO    +8613973400930    liaoaj163@163.com    Loudi central hospital Recruiting Loudi, Hunan, China, 417000 Contact: FENGQIAN SONG    +8615873890651       Shaoyang Central Hospital Recruiting Shaoyang, Hunan, China, 422000 Contact: CHAOMIN LI    +8613762857236       The Affiliated Hospital Of YongZhou Vocational Technical College Recruiting Yongzhou, Hunan, China, 425000 Contact: MING YANG    +8613974621123 Less <<
NCT03658733 Helicobacter Pylori Infection Phase 4 Not yet recruiting October 31, 2019 China, Shandong ... More >> Xiuli Zuo Recruiting Jinan, Shandong, China Contact: Xiuli Zuo, PhD,MD    15588818685 ext 053188369277    zuoxiuli@sina.com    Sub-Investigator: Yue Li, MD          Sub-Investigator: Chaoran Ji, MD Less <<
NCT03658746 Helicobacter Pylori Infection Phase 4 Not yet recruiting April 30, 2020 China, Shandong ... More >> Qilu hosipital Jinan, Shandong, China, 257000 Less <<
NCT00520949 Treatment of Helicobacter Pylo... More >>ri Less << Not Applicable Completed - Pakistan ... More >> Aga Khan University Hospital Karachi, Sindh, Pakistan, 74800 Less <<
NCT03616405 Helicobacter Pylori Infection Phase 4 Not yet recruiting June 30, 2019 China, Shandong ... More >> Xiuli Zuo Jinan, Shandong, China Less <<
NCT03377933 Efficacy Gast... More >>ric Microbiota Safety Less << Not Applicable Not yet recruiting December 2018 -
NCT01805934 Rescue Therapy for Helicobacte... More >>r Pylori Less << Phase 2 Completed - China, Shanghai ... More >> Shanghai Renji Hospital Shanghai, Shanghai, China Less <<
NCT02894268 Helicobacter Pylori Infection Phase 4 Recruiting December 2019 China, Zhejiang ... More >> Sir Run Run Shaw Hospital,Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Weiling Hu, Attending    +86153-9705-9751    ringwh@163.com    Principal Investigator: Weiling Hu, Atrending Less <<
NCT03609892 Gastric Ulcer ... More >> Chronic Gastritis Gastric Cancer Helicobacter Pylori Infection Gastritis Less << Phase 4 Recruiting April 1, 2019 China, Shaanxi ... More >> Xijing Hosipital of Digestive Disease Recruiting Xi`an, Shaanxi, China, 710032 Contact: Yongquan Shi, professor    86-029-84771515    shiyquan@fmmu.edu.cn Less <<
NCT03716622 Helicobacter Pylori Phase 4 Recruiting October 1, 2020 China, Shandong ... More >> Qilu hosipital Recruiting Jinan, Shandong, China, 257000 Contact: Xiuli Zuo, MD,PhD    15588818685 ext 053188369277    zuoxiuli@sina.com    Sub-Investigator: Chen Qiao, MD          Sub-Investigator: Yueyue Li, MD,PhD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.44mL

0.89mL

0.44mL

22.21mL

4.44mL

2.22mL

44.41mL

8.88mL

4.44mL

References

 

Historical Records

Categories